Longitudinal assessment of olfactory function in idiopathic REM sleep behavior disorder

Parkinsonism and Related Disorders

Volumn 19, Issue 6, 2013, Pages 600-604

  Iranzo, Alex ^a,b,c   Serradell, Mónica ^a,b   Vilaseca, Isabel ^a,d   Valldeoriola, Francesc ^a,b,c   Salamero, Manel ^a,c   Molina, Cristina ^a   Santamaria, Joan ^a,b,c   Tolosa, Eduardo ^a,b,c  

^a HOSPITAL CLÍNIC   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Olfaction; Parkinson disease; REM sleep behavior disorder

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROLOGIC EXAMINATION; OLFACTORY DISCRIMINATION; OUTCOME ASSESSMENT; PARASOMNIA; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMELL THRESHOLD TEST; SMELLING; SMELLING DISORDER; UNIVERSITY OF PENNSYLVANIA SMELL IDENTIFICATION TEST; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; COMPLICATION; LONGITUDINAL STUDY; MIDDLE AGED; OLFACTION DISORDERS; PERCEPTIVE THRESHOLD; PHYSIOLOGY; POLYSOMNOGRAPHY; SEVERITY OF ILLNESS INDEX; TIME;

AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OLFACTION DISORDERS; POLYSOMNOGRAPHY; REM SLEEP BEHAVIOR DISORDER; SENSORY THRESHOLDS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84891511038     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.02.009     Document Type: Article

References (30)

1. Tolosa E., Gaig C., Santamaria J., Compta Y. Diagnosis and the premotor phase of Parkinson disease. Neurology 2009, 72(Suppl. 2):S51-S58.
2. Boeve B. REM sleep behavior disorder. Ann N Y Acad Sci 2010, 1184:15-54.
3. Doty R.L., Deems D.A., Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988, 38:1237-1244.
4. Schenck C.H., Bundlie S.R., Mahowald M.W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 1996, 46:388-392.
5. Iranzo A., Molinuevo J.L., Santamaria J., Serradell M., Martí M.J., Valldeoriola F., et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disease: a descriptive study. Lancet Neurol 2006, 5:572-577.
6. Postuma R.B., Gagnon J.F., Vendette M., Fantini M.L., Massicotte-Marquez J., Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009, 72:1296-1300.
7. Stiasny-Kolster K., Doerr Y., Möller J.C., Höffken T.M., Behr T.M., Oertel W.H., et al. Combination of " idiopathic" REM sleep behavior disorder and olfactory dysfunction as possible indicator for α-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 2005, 128:126-137.
8. Fantini M.L., Postuma R.B., Montplaisir J., Ferini-Strambi L. Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder. Brain Res Bull 2006, 70:386-390.
9. Miyamoto T., Miyamoto M., Iwanami M., Suzuki K., Inoue Y., Hirata K. Odor identification test as an indicator of idiopathic REM sleep behavior disorder. Mov Disord 2009, 24:268-273.
10. Iranzo A., Lomeña F., Stockner H., Valldeoriola F., Vilaseca I., Salamero M., et al. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 2010, 9:1070-1077.
11. Postuma R.B., Gagnon J.F., Vendette M., Desjardins C., Montplaisir J. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 2011, 69:811-818.
12. Iranzo A., Valldeoriola F., Lomeña F., Molinuevo J.L., Serradell M., Salamero M., et al. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 2011, 10:797-805.
13. Fahn S., Elton R.L., members of the UPDRS Development Committee Unified Parkinson's disease rate scale. Recent developments in Parkinson's disease 1987, vol. 2:153-163. Macmillan Health Care Information, Florharm Park, NJ.
14. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinic-pathological study of 100 cases. J Neurol Neurosurg Psychiatr 1992, 55:181-184.
15. Gilman S., Low P.A., Quinn N., et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999, 163:94-98.
16. Doty R.L. The Smell Identification Test™ administration manual 1995, Sensonics, Inc., Philadephia. 3rd ed.
17. Doty R.L. The Smell Threshold Test™ administration manual 2000, Sensonics, Inc., Philadephia.
18. Lötsch J., Reichmann H., Hummel T. Different odor tests contribute differently to the evaluation of olfactory loss. Chem Senses 2008, 33:17-21.
19. Westervelt H.J., Stern R.A., Tremont G. Odor identification deficits in diffuse Lewy body disease. Cogn Behav Neurol 2003, 16:93-99.
20. Berendse H.W., Booji J., Francot C.M.J.E., et al. Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with decreased sense of smell. Ann Neurol 2001, 50:34-41.
21. Ponsen M.M., Stoffers D., Booji J., van Eck-Smit B.L.F., Ech Wolters, Berendse H.W. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004, 56:173-181.
22. Ross, Petrovitch H., Abbot R.D., et al. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 2008, 63:167-173.
23. Herting B., Schulze S., Reichmann H., Haehner A., Hummel T. A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease. J Neurol 2008, 255:367-370.
24. Baba T., Kikuchi A., Hirayama K., et al. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study. Brain 2012, 135:161-169.
25. 123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations. J Neurol 2011, 258:1126-1132.
26. Ibarretxe-Bilbao N., Junqué C., Martí M.J., et al. Olfactory impairment in Parkinson's disease and white matter abnormalities in ventral olfactory areas: a voxel-based diffusion tensor imaging. Mov Disord 2010, 25:1888-1894.
27. Haehner A., Hummel T., Hummel C., Sommer U., Junghans S., Reichmann H. Olfactory loss may be a first sign of idiopathic Parkinson's disease. Mov Disord 2007, 839-842.
28. 123I]-meta-iodobenzylguanidine myocardial scintigraphy and olfactory test. Parkinsonism Relat Disord 2011, 17:698-700.
29. Glass P.G., Lees A.J., Mathias C., et al. Olfaction in pathologically proven patients with multiple system atrophy. Mov Disord 2012, 27:327-328.
30. Braak H., Rüb U., Gai W.P., Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003, 110:517-536.